Business
MedMira Completes Submission for World Health Organization's New Prequalification Diagnostics Programme
Building on Global Public Health Sales Channels including USAID and PAHO HALIFAX, June 24 /CNW/ -...
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\n\nBuilding on Global Public Health Sales Channels including USAID and PAHO\n\n\nHALIFAX, June 24 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,\nNASDAQ: MMIRF), a developer and marketer of rapid diagnostics, said today that\nit has submitted the MedMira Rapid HIV Test for evaluation in the World Health\nOrganization's (WHO) new Prequalification Diagnostics Programme launched on\nJune 16, 2008. The Programme is designed to provide guidance and advice on\nquality health technologies, including rapid tests for HIV, that are supplied\nto people around the globe through various public health agencies including\nthe United Nations.\n\n\n"We have been steadily building our global public health sales channels\nover the past year, establishing MedMira as an approved vendor with USAID and\nthe Pan American Health Organization (PAHO). The WHO Programme will be another\nopportunity for us to tap into tender opportunities and large scale public\nhealth initiatives in developing nations," said Hermes Chan, President and\nCEO, MedMira Inc. "We believe that the MedMira Rapid HIV Test will exceed all\nof the requirements and characteristics that the WHO is seeking in the rapid\ndiagnostics that are being evaluated and approved under this new program."\n\n\nAccording to the WHO guidelines, the Programme is designed to increase\naccess to quality diagnostics that are both affordable and appropriate for use\nin resource-constrained settings such as mobile clinics in rural areas, which\nhave little or no access to traditional healthcare tools. The MedMira Rapid\nHIV Test is built on the Company's patented rapid flow-through technology\nplatform, which is the product engine behind MedMira's successful line of\nrapid HIV tests that have been approved in Canada, the United States, the\nEuropean Union, China, Russia, and India. The test requires no specialized\ntraining or equipment to perform, and uses a whole blood, serum or plasma\nspecimen to deliver results in just three minutes. The MedMira Rapid HIV Test\nhas an extended shelf-life with no refrigeration required, making it ideally\nsuited for all types of testing environments. All of MedMira's tests are\nmanufactured in Canada under ISO and GMP standards.\n\n\nAbout MedMira\n\n\nMedMira is a leading developer, manufacturer, and marketer of advanced\nrapid...